Evaluation of Reliability and Validity of Reflectance Pulse Oximeter in Screening Children With Obstructive Sleep Apnea

Sponsor
Guangzhou Institute of Respiratory Disease (Other)
Overall Status
Recruiting
CT.gov ID
NCT05001464
Collaborator
(none)
100
1
15
6.7

Study Details

Study Description

Brief Summary

Polysomnography (PSG) has some disadvantages, such as time-consuming, effort-consuming, long appointment time and high cost. During PSG examination, multiple sensors need to be placed in the patient's head, face, neck, chest and limbs, and sensors are needed to monitor data throughout the night. It is difficult for young children to cooperate, and it is easy to fail due to inaccurate sensor signal acquisition. PSG examination may miss diagnosis or underestimate the disease due to the first night effect. Based on the above reasons, the application of PSG in clinic, especially in pediatric patients is limited. The reflective optical path detection can be used to measure the peripheral blood oxygen saturation in the flat part of human skin. The investigators intend to use a reflectance pulse oximeterto evaluate its reliability and validity in the diagnosis of OSA in children at the same time as PSG.

Condition or Disease Intervention/Treatment Phase
  • Device: reflectance pulse oximeter

Detailed Description

During PSG examination, the participants wear reflectance pulse oximeter for continuous monitoring. Use PSG to record EEG, oculogram, chin electromyography, body movement, chest and abdomen movement, nose and mouth airflow, snoring, electrocardiogram, blood oxygen saturation and finger pulse monitoring. The effective monitoring time should be at least 6 hours. Oxygen desaturation index (ODI), average blood oxygen saturation, minimum blood oxygen saturation, percentage of blood oxygen saturation less than 90% in the whole recording time (TS90%), fastest heart rate, slowest heart rate and average heart rate are recorded by reflectance pulse oximeter. To compare the effective time (TST), the total number of hypoxemia events, the coincidence rate of comparing each hypoxemia event, identifying OSA, and identifying moderate and severe OSA by PSG and reflectance pulse oximeter.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Evaluation of Reliability and Validity of Reflectance Pulse Oximeter in Screening Children With Obstructive Sleep Apnea
Actual Study Start Date :
Jun 1, 2021
Anticipated Primary Completion Date :
May 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Reflectance Pulse Oximeter

The participants wear reflectance pulse oximeter for continuous monitoring when carrying out PSG . Oxygen desaturation index (ODI), average blood oxygen saturation, minimum blood oxygen saturation, percentage of blood oxygen saturation less than 90% in the whole recording time (TS90%), fastest heart rate, slowest heart rate and average heart rate are recorded by reflectance pulse oximeter.

Device: reflectance pulse oximeter
Wearing reflectance pulse oximeter at the same time on the night of PSG examination

Outcome Measures

Primary Outcome Measures

  1. Coincidence rate of total number of oxygen reduction events [1 night]

    The ratio of the number of oxygen reduction events recorded by reflectance pulse oximeter consistent with PSG to the total oxygen reduction events of PSG

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Snoring more than 3 nights per week in the last month

  2. Pediatric sleep questionnaires score ≥ 0.33

Exclusion Criteria:
  1. Acute exacerbation of asthma

  2. Pulmonary infection

  3. Heart disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 151 Yanjiang Road Guangzhou Guangdong China 510120

Sponsors and Collaborators

  • Guangzhou Institute of Respiratory Disease

Investigators

  • Principal Investigator: Jinping Zheng, Professor, Guangzhou Institute of Respiratory Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
LI-HONG SUN, Researcher, Guangzhou Institute of Respiratory Disease
ClinicalTrials.gov Identifier:
NCT05001464
Other Study ID Numbers:
  • PP of GIRD
First Posted:
Aug 12, 2021
Last Update Posted:
Aug 12, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 12, 2021